Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1952 1
1954 2
1955 1
1956 2
1957 2
1958 2
1959 3
1961 2
1964 1
1965 1
1967 2
1968 1
1970 2
1971 1
1973 1
1974 1
1978 3
1979 1
1980 1
1981 1
1982 2
1983 5
1985 5
1986 2
1987 2
1988 1
1989 2
1990 3
1992 2
1993 1
1994 8
1995 2
1996 2
1997 3
1998 4
1999 3
2000 2
2001 2
2002 1
2003 3
2004 1
2005 8
2006 8
2007 7
2008 8
2009 10
2010 3
2011 3
2012 7
2013 7
2014 2
2015 11
2016 11
2017 8
2018 7
2019 13
2020 18
2021 19
2022 15
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Timothy Fields-Building networks for success.
Greenberg M, Lowrie K, Burger J, Fields T. Greenberg M, et al. Among authors: fields t. Risk Anal. 2022 Nov;42(11):2469-2472. doi: 10.1111/risa.14058. Risk Anal. 2022. PMID: 36625054 No abstract available.
Pipeline Therapies for Gout.
Yip K, Braverman G, Yue L, Fields T. Yip K, et al. Among authors: fields t. Curr Rheumatol Rep. 2024 Mar;26(3):69-80. doi: 10.1007/s11926-023-01128-3. Epub 2023 Dec 22. Curr Rheumatol Rep. 2024. PMID: 38133712 Review.
The Challenges of Approaching and Managing Gout.
Fields TR. Fields TR. Rheum Dis Clin North Am. 2019 Feb;45(1):145-157. doi: 10.1016/j.rdc.2018.09.009. Rheum Dis Clin North Am. 2019. PMID: 30447743 Free article. Review.
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM; COVID-19 Global Rheumatology Alliance. Strangfeld A, et al. Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27. Ann Rheum Dis. 2021. PMID: 33504483 Free PMC article.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammat… See abstract for full author list ➔ Izadi Z, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639. JAMA Netw Open. 2021. PMID: 34661663 Free PMC article.
DOT1L Mediated Gene Repression in Extensively Self-Renewing Erythroblasts.
Borosha S, Ratri A, Ghosh S, Malcom CA, Chakravarthi VP, Vivian JL, Fields TA, Rumi MAK, Fields PE. Borosha S, et al. Among authors: fields ta. Front Genet. 2022 Mar 23;13:828086. doi: 10.3389/fgene.2022.828086. eCollection 2022. Front Genet. 2022. PMID: 35401699 Free PMC article.
253 results